Description: The primary purposes of the study are the following: 1. Compare recent industry experience for individual life waiver of premium (ILWOP) insurance products to the claim incidence and claim termination rates from the 1952 SOA Disability Table; 2. Analyze actual-to-expected (A/E) claim incidence and claim termination ratios across key segments such as gender, attained age, etc.; 3. Develop an illustrative experience basis for calculating policy and claim reserves based on the results from the A/E studies; and 4. Compare reserves calculated using experience assumptions to the reserves calculated using the 1952 SOA Disability Table for an illustrative cohort of ILWOP business.

Description: The primary purposes of the study are the following: 1. Compare recent industry experience for individual life waiver of premium (ILWOP) insurance products to the claim incidence and claim termination rates from the 1952 SOA Disability Table; 2. Analyze actual-to-expected (A/E) claim incidence and claim termination ratios across key segments such as gender, attained age, etc.; 3. Develop an illustrative experience basis for calculating policy and claim reserves based on the results from the A/E studies; and 4. Compare reserves calculated using experience assumptions to the reserves calculated using the 1952 SOA Disability Table for an illustrative cohort of ILWOP business.

Description: In this session, the presenters will discuss (1) results from a recent study of credibility applications in the pricing of group long term disability business, (2) morbidity experience from individual disability business, and (3) lessons can be learned from each line of business.

Description: This paper summarizes the results of a survey of waiver of premium/monthly deduction rider assumptions and experience.

Description: This paper summarizes the results of a survey of waiver of premium/monthly deduction rider assumptions and experience.

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through September 2021, as compared to prior period baseline mortality results. This new report is an update to the survey report released in July 2021, which contained data through March 2021.

Description: The Group Life COVID-19 Mortality Survey gathers a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic through March 2021, as compared to prior period baseline mortality results. This new report is an update to the survey report released in December 2020, which contained data through August 2020.

Description: The purpose of this survey is to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, as compared to prior period baseline mortality results. The datasets for this report encompass all Group Term Life claims reported to participating carriers as of August 31, 2020. The Committee is grateful that 20 of the top 21 U.S. Group Term Life insurers are participating in this survey, with market share representing roughly 90% of the industry.